Agilent Technologies Announces Q2 2024 Financial Results and New Share Repurchase Program

Details

announced financial results for the second fiscal quarter of 2024, reporting a revenue of $1.57 billion, down 8.4% year-over-year. GAAP net income was $308 million, or $1.05 per share, while non-GAAP net income was $356 million, or $1.22 per share. The company revised its full-year revenue outlook to $6.420 billion to $6.500 billion and announced a new $2.0 billion share repurchase program authorized by the Board of Directors.

Items reported

Exhibits (1)

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.